Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002392407 | SCV002708160 | uncertain significance | Cardiovascular phenotype | 2022-08-16 | criteria provided, single submitter | clinical testing | The p.G51C variant (also known as c.151G>T), located in coding exon 1 of the PCSK9 gene, results from a G to T substitution at nucleotide position 151. The glycine at codon 51 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004808309 | SCV005431355 | uncertain significance | Hypercholesterolemia, autosomal dominant, 3 | 2024-03-05 | criteria provided, single submitter | clinical testing |